Scholarly Index
Michael A. Davies
The University of Texas MD Anderson Cancer Center; 50,783 total citations; 638 total publications; best world rank #32
The University of Texas MD Anderson Cancer Center
50,783Total citations
638Total publications
99H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Melanoma and MAPK Pathways | Lifetime | 32 | US 16 | 99.58 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 63 | US 38 | 99.33 |
| Brain Metastases and Treatment | Lifetime | 88 | US 63 | 99.17 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 350 | US 191 | 99.17 |
| Cutaneous Melanoma Detection and Management | Lifetime | 102 | US 45 | 99.00 |
| CAR-T cell therapy research | Lifetime | 314 | US 191 | 99.02 |
| HER2/EGFR in Cancer Research | Lifetime | 425 | US 200 | 98.20 |
| Computational Drug Discovery Methods | Lifetime | 660 | US 252 | 97.33 |
| Protein Degradation and Inhibitors | Lifetime | 514 | US 259 | 96.32 |
| Cancer Mechanisms and Therapy | Lifetime | 747 | US 295 | 93.27 |
| Melanoma and MAPK Pathways | 2021-2025 | 43 | US 14 | 97.41 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 639 | US 239 | 97.59 |
| Brain Metastases and Treatment | 2021-2025 | 110 | US 61 | 96.01 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 409 | US 103 | 89.72 |